Contact
    Start Publications Electrosprayed mesoporous particles for improved aqueous ...
    ←  Publication Finder
    Attension

    Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation

    Year: 2018

    Journal: J. Control. Release, Volume 278, MAY 28, page 142–155

    Authors: Sayed, Elshaimaa; Karavasili, Christina; Ruparelia, Ketan; Haj-Ahmad, Rita; Charalambopoulou, Georgia; Steriotis, Theodore; Giasafaki, Dimitra; Cox, Paul; Singh, Neenu; Giassafaki, Lefki-Pavlina N.; Mpenekou, Aggeliki; Markopoulou, Catherine K.; Vizirianakis, Ioannis S.; Chang, Ming-Wei; Fatouros, Dimitrios G.; Ahmad, Zeeshan

    Organizations: Egyptian Culture Centre; Educational Bureau in London; EPSRC (EPSRC EHDA Network)

    Keywords: Mesoporous silica; Chalcones; Electrohydrodynamic atomization; Electrospraying; Poor solubility; Ex vivo; Molecular modeling; Cytocompatibility

    Encapsulation of poorly water-soluble drugs into mesoporous materials (e.g. silica) has evolved as a favorable strategy to improve drug solubility and bioavailability. Several techniques (e.g. spray drying, solvent evaporation, microwave irradiation) have been utilized for the encapsulation of active pharmaceutical ingredients (APIs) into inorganic porous matrices. In the present work, a novel chalcone (KAZ3) with anticancer properties was successfully synthesized by Claisen-Schmidt condensation. KAZ3 was loaded into mesoporous (SBA-15 and MCM-41) and non-porous (fumed silica, FS) materials via two techniques; electrohydrodynamic atomization (EHDA) and solvent impregnation. The effect of both loading methods on the physicochemical properties of the particles (e.g. size, charge, entrapment efficiency, crystallinity, dissolution and permeability) was investigated. Results indicated that EHDA technique can load the active in a complete amorphous form within the pores of the silica particles. In contrast, reduced crystallinity (similar to 79%) was obtained for the solvent impregnated formulations. EHDA engineered formulations significantly improved drug dissolution up to 30-fold, compared to the crystalline drug. Ex vivo studies showed EHDA formulations to exhibit higher permeability across rat intestine than their solvent impregnated counterparts. Cytocompatibility studies on Caco-2 cells demonstrated moderate toxicity at high concentrations of the anticancer agent. The findings of the present study clearly show the immense potential of EHDA as a loading technique for mesoporous materials to produce poorly water-soluble API carriers of high payload at ambient conditions. Furthermore, the scale up potential in EHDA technologies indicate a viable route to enhance drug encapsulation and dissolution rate of loaded porous inorganic materials.
    View publication